WallStreetZen

NASDAQ: AZN
Astrazeneca Plc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for AZN

Based on 4 analysts offering 12 month price targets for Astrazeneca Plc.
Min Forecast
$56.00+5.16%
Avg Forecast
$63.85+19.91%
Max Forecast
$69.40+30.33%

Should I buy or sell AZN stock?

Strong Buy
Strong Buy
5 analysts 71.43%
Buy
0 analysts 0%
Hold
2 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Forecast return on equity

Is AZN forecast to generate an efficient return?
Company
45.19%
Industry
75.54%
Market
61.82%
AZN's Return on Equity is forecast to be high in 4 years (45.19%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is AZN forecast to generate an efficient return on assets?
Company
8.59%
Industry
16.98%
Market
19.68%
AZN is forecast to generate lower Return on Assets (8.59%) than the US Drug Manufacturers - General industry average (16.98%)
Forecast

AZN earnings per share forecast

What is AZN's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$2.59+172.89%
Avg 2 year Forecast
$4.42+365.61%
Avg 3 year Forecast
$3.73+292.11%
AZN's earnings are forecast to grow at an exceptional rate of 65.83% per year
Forecast

AZN revenue forecast

What is AZN's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$31.0B+19.94%
Avg 2 year Forecast
$35.3B+36.46%
Avg 3 year Forecast
$39.2B+51.45%
AZN's revenue is forecast to grow at a rate of 14.84% per year, which is not exceptional
Forecast

AZN earnings growth forecast

How is AZN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
65.83%
Industry
25.04%
Market
20.34%
AZN's earnings are forecast to grow faster (65.83% per year) than the US Drug Manufacturers - General industry average (25.04%)
Forecast
AZN's earnings are forecast to grow faster (65.83% per year) than the US market average (20.34%)
Forecast
AZN's earnings are forecast to grow faster (65.83% per year) than the risk-free savings rate (1.1%)
Forecast

AZN revenue growth forecast

How is AZN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
14.84%
Industry
6.45%
Market
14.82%
AZN's revenues are forecast to grow faster (14.84% per year) than the US Drug Manufacturers - General industry average (6.45%)
Forecast
AZN's revenues are forecast to grow faster (14.84% per year) than the US market average (14.82%)
Forecast

Astrazeneca Stock Forecast FAQ

Is Astrazeneca Stock a good buy in 2020, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: AZN) stock is to Strong Buy AZN stock.

Out of 7 analysts, 5 (71.43%) are recommending AZN as a Strong Buy, 0 (0%) are recommending AZN as a Buy, 2 (28.57%) are recommending AZN as a Hold, 0 (0%) are recommending AZN as a Sell, and 0 (0%) are recommending AZN as a Strong Sell.

What is AZN's Price Target?

According to 4 Wall Street analysts that have issued a 1 year AZN price target, the average AZN price target is $63.85, with the highest AZN stock price forecast at $69.40 and the lowest AZN stock price forecast at $56.00.

On average, Wall Street analysts predict that Astrazeneca's share price could reach $63.85 by Jan 20, 2022. The average Astrazeneca stock price prediction forecasts a potential upside of 19.91% from the current AZN share price of $53.25.

What is AZN's earnings growth forecast for 2021-2023?

(NASDAQ: AZN) Astrazeneca's forecast annual earnings growth rate of 65.83% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 25.04%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 20.34%.

Astrazeneca's earnings in 2020 is $2,416,000,000.On average, 4 Wall Street analysts forecast AZN's earnings for 2021 to be $3,401,360,000, with the lowest AZN earnings forecast at $3,201,280,000, and the highest AZN earnings forecast at $3,673,600,000. On average, 3 Wall Street analysts forecast AZN's earnings for 2022 to be $5,803,369,600, with the lowest AZN earnings forecast at $4,185,280,000, and the highest AZN earnings forecast at $8,987,200,000.

In 2023, AZN is forecast to generate $4,887,200,000 in earnings, with the lowest earnings forecast at $4,723,200,000 and the highest earnings forecast at $5,051,200,000.

What is AZN's revenue growth forecast for 2021-2023?

(NASDAQ: AZN) Astrazeneca's forecast annual revenue growth rate of 14.84% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.45%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 14.82%.

Astrazeneca's revenue in 2020 is $25,871,000,000.On average, 2 Wall Street analysts forecast AZN's revenue for 2021 to be $40,710,048,000,000, with the lowest AZN revenue forecast at $39,949,088,000,000, and the highest AZN revenue forecast at $41,471,008,000,000. On average, 2 Wall Street analysts forecast AZN's revenue for 2022 to be $46,318,192,000,000, with the lowest AZN revenue forecast at $45,450,304,000,000, and the highest AZN revenue forecast at $47,186,080,000,000.

In 2023, AZN is forecast to generate $51,406,128,000,000 in revenue, with the lowest revenue forecast at $50,691,744,000,000 and the highest revenue forecast at $52,120,512,000,000.

What is AZN's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: AZN) Astrazeneca's current Earnings Per Share (EPS) is $0.95. On average, analysts forecast that AZN's EPS will be $2.59 for 2021, with the lowest EPS forecast at $2.44, and the highest EPS forecast at $2.80. On average, analysts forecast that AZN's EPS will be $4.42 for 2022, with the lowest EPS forecast at $3.19, and the highest EPS forecast at $6.85. In 2023, AZN's EPS is forecast to hit $3.73 (min: $3.60, max: $3.85).

What is AZN's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: AZN) forecast ROE is 45.19%, which is considered strong.

What is AZN's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: AZN) forecast ROA is 8.59%, which is lower than the forecast US Drug Manufacturers - General industry average of 16.98%.
WallStreetZen
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatistics
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics